RxDoctor Payments DataLook up a doctor →

James McCarty

Pediatric Infectious Diseases · Madera, CANPI 1598777500

Payments from drug & device makers

$877,182in general payments, 2019–2025

Across 257 payments — averaging $3413.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Emergent Biosolutions Inc.$790K
  • Bavarian Nordic A/s$87K
$910,679in research payments, 2019–2025

Across 217 payments — averaging $4196.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Emergent Biosolutions Inc.$911K

What the payments were for

  • Consulting fees$859,85498%
  • Speaking & faculty fees$2,6690%
  • Travel & lodging$14,1632%
  • Food & beverage$4950%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Emergent Biosolutions Inc.243$789,705
Bavarian Nordic A/s14$87,476

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$877,182 in reported general payments places this provider in the 90th percentile of 83 pediatric infectious diseases providers in California.

See all pediatric infectious diseases providers in California

Other pediatric infectious diseases in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →